Sound Bioventures
Overview
Sound Bioventures is a venture capital firm investing in early-stage life sciences companies developing novel therapeutics for unmet medical needs. The firm focuses on private companies in Europe and the United States that are about to enter the clinical stage of drug development. Sound Bioventures aims to support the advancement of innovative medicines addressing significant clinical needs. The firm's investment strategy emphasizes an active, hands-on approach, with the founding team bringing considerable operational and venture capital investment experience. They invest in companies where private investors can finance the research and development program all the way to regulatory approval. Sound Bioventures operates from key locations in Copenhagen, Stockholm, and Washington D.C., reflecting its commitment to both Scandinavian and international biotech ecosystems. Sound Bioventures has a track record of supporting companies in various therapeutic areas. For instance, in June 2024, the firm invested in NephroDI Therapeutics, a U.S.-based company developing treatments for pediatric kidney diseases. In April 2024, Sound Bioventures participated in a £19 million financing round for Theolytics, a UK biotechnology company focused on oncolytic viral therapies. These investments demonstrate the firm's dedication to advancing innovative treatments for unmet medical needs across different regions and therapeutic areas.
Investment Focus
- Companies developing novel therapeutics addressing significant clinical unmet needs
- Private companies in Europe and the United States about to enter the clinical stage of drug development
- Companies where private investors can finance the R&D program to regulatory approval
Portfolio Companies
Reach Sound Bioventures directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Sound Bioventures
What sectors does Sound Bioventures invest in?
Sound Bioventures invests in Healthcare, Pharmaceuticals and Biotechnology, and is based in Malmö, Sweden. Sound Bioventures is listed as a venture capital in the ConnectSafely investor database.
What stage does Sound Bioventures invest at?
Sound Bioventures backs companies at Early Stage, Series A, Series B and Growth, writing cheques of 1.5M - 3M.
Which regions does Sound Bioventures invest in?
Sound Bioventures invests across United States, Denmark and Sweden.
Who are the partners at Sound Bioventures?
Team members listed for Sound Bioventures include Anna Gran (Principal) and Ester Sklarsky (Principal).
What companies has Sound Bioventures invested in?
Sound Bioventures's portfolio includes BOOST Pharma, Theolytics and NephroDI Therapeutics.
How do I contact Sound Bioventures?
Sound Bioventures's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
